This is a correction by the author of the article entitled "Loss of the histone methyltransferase EZH2 induces multidrug resistance in acute myeloid leukemia". The article was published in Nature Medicine online on January 7, 2026. The article's DOI is 10.1038/s41591-025-04159-8. The correction refers to the original research on the loss of the enzyme EZH2, which is a histone methyltransferase. This loss leads to multidrug resistance in patients with acute myeloid leukemia. Acute myeloid leukemia is a serious type of blood cancer. Specific statistics or other details from the original study are not included in the correction.